Palaran, Kheysia Claire A.
HRN: 27-25-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/12/2025
10/18/2025
IVT
200mg
Q8H
Inguinal Hernia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes